The history of Viagra, and its developer copyright, presents a challenging case study for investors. At first a blockbuster drug, yielding billions in income, its intellectual property lapse created a deluge of knock-off medications, significantly eroding its dominance. While certain businesses may attempt to capitalize on related treatments , the